Related Experiment Video
Updated: Mar 4, 2026

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
3.6K
Paediatrics primary myelofibrosis and acute stroke: A rare presentation
Wajida Mazher1, Ather Hasan Rizvi2, Arsalan Majeed Adam2
1Civil Hospital Karachi, Pakistan.
JPMA. the Journal of the Pakistan Medical Association
|April 20, 2017
Summary
Idiopathic myelofibrosis is a rare myeloproliferative disorder. This case highlights a rare pediatric presentation with stroke and extramedullary hematopoiesis.
Area of Science:
- Hematology
- Pediatric Oncology
- Pathology
Background:
- Idiopathic myelofibrosis (IMF) is a rare myeloproliferative neoplasm characterized by bone marrow fibrosis.
- Pediatric primary myelofibrosis is exceptionally rare, posing diagnostic and therapeutic challenges.
Observation:
- A 6-year-old male presented with pallor, petechiae, and gingival bleeding.
- Bone marrow aspirate revealed scattered erythroid and myeloid precursors.
- Trephine biopsy showed significant fibrotic activity and histiocyte clusters.
Findings:
- The patient was diagnosed with pediatric primary myelofibrosis based on bone marrow biopsy findings.
- The patient subsequently experienced a stroke, leading to left-sided hemiparesis.
- MRI confirmed an intraparenchymal hemorrhage and meningeal extramedullary hematopoiesis.
Implications:
- This case underscores the rarity and complex presentation of pediatric primary myelofibrosis.
- The occurrence of stroke and extramedullary hematopoiesis highlights potential serious complications.
- Further research into pediatric myelofibrosis is warranted to improve understanding and management.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
570
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
570
Clot Retraction and Fibrinolysis
9.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K

